Description
Ovalbumin (323-339) is an antigenic peptide fragment of ovalbumin that contains a CD4+ T cell epitope. This fragment is an MHC II-restricted epitope that is used in vaccines to stimulate a Th2 immune response.
Product Unit Size | Cost | Quantity | Stock |
---|
Ovalbumin (323-339) is an antigenic peptide fragment of ovalbumin that contains a CD4+ T cell epitope. This fragment is an MHC II-restricted epitope that is used in vaccines to stimulate a Th2 immune response.
Purity | ≥98% |
---|---|
Formula | C74H120N26O25 |
Formula Wt. | 1773.93 |
Synonym | OVA (323-339) |
Solubility | Soluble in water. |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Nakajima-Adachi H, Koike E, Totsuka M, et al. Two distinct epitopes on the ovalbumin 323-339 peptide differentiating CD4+ T cells into the Th2 or Th1 phenotype. Biosci Biotechnol Biochem. 2012;76(10):1979-81. PMID: 23047087.
Ichikawa K, Kagamu H, Koyama K, et al. Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity. Vaccine. 2012 Sep 21;30(43):6190-7. PMID: 22889826.
Sun LZ, Elsayed S, Aasen TB, et al. Comparison between ovalbumin and ovalbumin peptide 323-339 responses in allergic mice: humoral and cellular aspects. Scand J Immunol. 2010 May;71(5):329-35. PMID: 20500683.
Deubiquitinating enzyme inhibitor.
Kavalactone originally found in Piper methystic...
Mycotoxin contaminant found in cereal grains.
Alkaloid found in Sophora.
p110α PI3K inhibitor.
Macrolide lactone found in Bugula; TLR4 activat...
STING inhibitor
Endogenous tachykinin peptide, involved in infl...
EGFR inhibitor.
BH3 mimetic; Bcl-2 and Bcl-xl inhibitor.
Calcium channel blocker.
Endogenous opioid peptide; μOR agonist.
Cortisol derivative; glucocorticoid agonist.
Nucleoside (deoxyadenosine) analog; DNA chain t...
Coccidiostat.
Recombinant protein containing Treponema pallid...
Peptide, neurotensin analog.
TLR7 agonist
Statin; HMG-CoA reductase inhibitor.
c-Raf, RET, VEGFR1 inhibitor, potential HMT inh...